RxDoctor Payments Data

Jimmy Edmond, MD

Internal Medicine · Spring Hill, FLNPI 1821011974

Payments from drug & device makers

$840in general payments, 2019–2025

Across 43 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$183
  • Stryker$144
  • Pfizer$88
  • Amarin Pharma, Inc.$86
  • Amgen$79
  • AbbVie$52
  • plus $207 from 9 others

What the payments were for

  • Food & beverage$840100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$840 in reported general payments places this provider in the 65th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Medicare billing

Part B allowed, 2024
$127,991
Medicare patients
220
Services billed
1,069

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$16,710
XareltoRivaroxaban12$9,755
EliquisApixaban15$8,139
Atorvastatin Calcium585$4,251
Levothyroxine Sodium265$3,934
Wixela InhubFluticasone Propion/Salmeterol19$3,213
Fluticasone-SalmeterolFluticasone Propion/Salmeterol36$3,139
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen106$3,133
PremproEstrogen,con/M-Progest Acet13$3,012
Novolin 70-30Insulin Nph Hum/Reg Insulin Hm30$2,944
Nifedipine ErNifedipine65$2,869
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen127$2,162
Levetiracetam16$1,602
Lisinopril436$1,565
Gabapentin126$1,563

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$183$16,71018 claims
PfizerEliquis, Prempro$88$11,15228 claims
Johnson & JohnsonXarelto$37$9,75512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 8,530 internal medicine providers in Florida.

Other internal medicine in Spring Hill

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →